medcareworld’s Post

In today’s fast-changing #healthcare world, using technology and cardiac biomarkers is key to shifting from reactive sick care to proactive health care. This not only boosts patient outcomes but also helps labs reach more people with their tests by using resources more effectively. Rhonda’s story shows the urgent need for a unified approach to tackling cardiovascular disease worldwide. To do this, we need to weave #diagnostic tools into every step of care and invest in training our healthcare professionals to use these tools to their fullest potential. At Roche, we work hand-in-hand with diagnostic labs to expand access to testing. This ensures that people like Rhonda get the timely, accurate diagnoses they need. Together, we can transform heart health and bridge the care gap. Read Rhonda’s story here: https://lnkd.in/dUDV2eu9 #HeartHealth #CVD #ActOnNCDs #HealthcareInnovation

🚨 Lord Darzi Report Highlights Urgent Need for Innovation in Cardiovascular Care and Beyond. 🚨 The recent Lord Darzi Report assesses patient access, quality of care and the overall performance of NHS England https://lnkd.in/eDrp9Q9v It also outlines the growing pressures on cardiovascular care. With heart disease still the leading cause of death, the report stresses the need for faster diagnosis, personalised treatment, and more efficient healthcare delivery. Ortus-iHealth is ready to support cardiologists in delivering the best possible care to their patients. We’re already addressing these challenges head-on. Our virtual ward platform provides cardiologists and cardiology service leads with: 💡 Remote monitoring of patients. 💡 Configurable care pathways tailored to each patient's specific needs. 💡 Integration with EHR systems for seamless care coordination. By streamlining the patient journey, Ortus-iHealth enables cardiologists to deliver faster, more personalised care—reducing hospitalisations and improving long-term patient outcomes. Read our case studies and how they are helping the NHS combat the challenges highlighted in the report https://lnkd.in/eQ4WvidW #Cardiology #CVD #DigitalHealth #VirtualWards #HealthcareInnovation #remotepatientmonitoring

Sharing research from one of our Denver Health emergency department physicians, Stacy Trent, MD, MPH, who with others conducted a randomized trial studying the effect of preoxygenation with noninvasive ventilation, as compared with preoxygenation with an oxygen mask, on the incidence of hypoxemia during tracheal intubation. The study was published in the New England Journal of Medicine NEJM Group. https://lnkd.in/gAefJ-mU #clinicalresearch #researchexcellence

Technology is a critical component of life-saving diagnosis and treatment. They must be built and designed to help healthcare professionals deliver the best care for patients. In the field of cardiology, we understand that early intervention is key. In this video highlighting Phillips Foundation's partnership with the World Heart Federation, we see how access to ultrasound technologies can enable effective screening and early diagnosis, preventing life-threatening events and improving patient outcomes. It is heartening to see this in action in APAC, starting with the Philippines, helping children and young people with rheumatic heart disease, along with medical training and greater support for healthcare workers. Beyond this and across other healthcare areas, there is so much more technology can do to address healthcare challenges and bring more equitable care to all.   Watch the innovation in action here: https://lnkd.in/evdkDA3c (philips-foundation.com)   #cardiovascularhealth #Philips

Did you know that there's a connection between the liver and the heart? Hepatitis can lead to heart issues, highlighting the importance of comprehensive health management. I recently spoke with Dr. Caroline Oritogun from the University of Jos Teaching Hospital, who provided valuable insights into this relationship. Understanding these connections can help improve patient care and outcomes. #Healthcare #Hepatitis #HeartHealth #LiverHealth #MedicalInsights #PatientCare #publichealth #nigeria #heart #cardiology #comorbidity #inflammation

🩺New study highlights higher amputation risks after revascularization in younger #PAD patients compared to older ones. Discover the insights and implications for treatment strategies in this TCTMD article ➡️ https://ow.ly/vOUO50SKiTP #PulseOnPAD #LimbSaver

50% of U.S. adults have hypertension, and half are uncontrolled. Erie County Medical Center's remote patient monitoring program is changing that. By combining tech, personalized care, and addressing SDOH, 74% of patients achieved BP control in just 3 months. 🔗 Learn more: https://bit.ly/3Lx82h9 #HealthcareInnovation #Hypertension #RemoteMonitoring #SDOH #PatientCare

The addition of dapagliflozin to standard care for critically ill patients and acute organ dysfunction did not improve clinical outcomes; however, confidence intervals were wide and could not exclude relevant benefits or harms for dapagliflozin. The primary outcome was a hierarchical composite of hospital mortality, initiation of kidney replacement therapy, and ICU length of stay through 28 days, analyzed using the win ratio method. Secondary outcomes included the individual components of the hierarchical outcome, duration of organ support–free days, ICU, and hospital stay, assessed using bayesian regression models.

Revisiting Race and the Benefit of RAS Blockade in Heart Failure A recent meta-analysis published in JAMA sheds light on the effectiveness of renin-angiotensin system (RAS) blockers in heart failure patients across different racial groups. Let's dive into the findings and their implications for patient care! Interactive Questions & Answers: Q1: What did the meta-analysis examine regarding RAS blockers? A1: The meta-analysis examined whether the benefit of RAS blockade in patients with heart failure with reduced ejection fraction differs between Black and non-Black patients. Q2: What were the key findings of the study? A2: Black patients had higher rates of hospitalization and death. The rate of reduction in the primary outcome (cardiovascular death or first hospitalization for heart failure) was comparable between Black and non-Black patients taking RAS blockers. However, Black patients had a smaller relative risk reduction in hospitalizations for heart failure. Case Study & Answer: Case Study: Maria, a 65-year-old Black woman with heart failure, was prescribed RAS blockers by her cardiologist. Despite her adherence to the medication, she experienced several hospitalizations. Her cardiologist reassured her that while her relative risk reduction in hospitalizations might be smaller, the absolute benefit of the medication is significant given her higher baseline risk. Q: How did the RAS blockers benefit Maria despite her higher hospitalization rates? A: The RAS blockers provided an absolute benefit by reducing the risk of cardiovascular death and hospitalizations, crucial for her given the higher baseline risk associated with her condition. Call to Action: If you or a loved one has heart failure, speak with your healthcare provider about the benefits of RAS blockers, regardless of race. Effective management of heart failure is vital for improving outcomes. Interactive Poll: Do you or someone you know use RAS blockers for managing heart failure? Yes, and it has been beneficial. No, not yet. I need more information. I’m not familiar with RAS blockers. Hashtags: #HeartFailure #RASBlockers #CardiovascularHealth #JAMA #HealthEquity #PatientCare #BlackHealth #HeartHealth #MedicalResearch #Pharmacology Stay informed about heart failure treatments and share your experiences with us!

Why Hospital EDs Are Adopting Cytovale’s Sepsis Test  – MedCity News - MedCity News Title: Why Hospital EDs Are Adopting Cytovale’s Sepsis Test – MedCity News #Introduction Hospital emergency departments (EDs) are increasingly turning to Cytovale's sepsis test to improve patient outcomes and streamline care processes. #The Challenge of Sepsis Diagnosis Sepsis is a life-threatening condition that requires early detection and prompt treatment to prevent complications. #Benefits of Cytovale's Sepsis Test Cytovale's test offers rapid results, allowing for timely intervention and improved patient outcomes. #Integration with Hospital IT Systems The seamless integration of Cytovale's sepsis test with hospital IT systems enhances workflow efficiency and data management. #Cost-Effect ai.mediformatica.com #sepsis #medical #diagnostics #cytovale #health #hospital #college #diagnostictest #froedtert #froedtertthemedicalcollegeofwisconsin #heart #heartattack #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3XfHdEU)